Engels JW - Search Results

1

Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras.

Scherr M, Maurer AB, Klein S, Ganser A, Engels JW, Grez M. Scherr M, et al. Among authors: engels jw. Gene Ther. 1998 Sep;5(9):1227-34. doi: 10.1038/sj.gt.3300716. Gene Ther. 1998. PMID: 9930324

2

Specific hammerhead ribozyme-mediated cleavage of mutant N-ras mRNA in vitro and ex vivo. Oligoribonucleotides as therapeutic agents.

Scherr M, Grez M, Ganser A, Engels JW. Scherr M, et al. Among authors: engels jw. J Biol Chem. 1997 May 30;272(22):14304-13. doi: 10.1074/jbc.272.22.14304. J Biol Chem. 1997. PMID: 9162065 Free article.

3

Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro.

Klebba C, Ottmann OG, Scherr M, Pape M, Engels JW, Grez M, Hoelzer D, Klein SA. Klebba C, et al. Among authors: engels jw. Gene Ther. 2000 Mar;7(5):408-16. doi: 10.1038/sj.gt.3301094. Gene Ther. 2000. PMID: 10694823

4

An assay system to detect the selective advantage of anti-HIV ribozyme expressing CD4+ T-lymphocytes.

Klein SA, Klebba C, Engels JW. Klein SA, et al. Among authors: engels jw. Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):629-34. doi: 10.1081/NCN-100002339. Nucleosides Nucleotides Nucleic Acids. 2001. PMID: 11563080

5

Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patients.

Geissler RG, Muth J, Maurer A, Mentzel U, Mag M, Engels JW, Hoelzer D, Ganser A. Geissler RG, et al. Among authors: engels jw. Ann Hematol. 1995 Aug;71(2):89-95. doi: 10.1007/BF01699252. Ann Hematol. 1995. PMID: 7544629

6

Identification and characterization of a highly efficient anti-HIV pol hammerhead ribozyme.

Müller-Kuller T, Capalbo G, Klebba C, Engels JW, Klein SA. Müller-Kuller T, et al. Among authors: engels jw. Oligonucleotides. 2009 Sep;19(3):265-72. doi: 10.1089/oli.2008.0150. Oligonucleotides. 2009. PMID: 19732019

7

RNAi activity of siRNAs modified with 2'-aminoalkyl-substituted fluorinated nucleobases.

Haas J, Mueller-Kuller T, Klein S, Engels JW. Haas J, et al. Among authors: engels jw. Nucleosides Nucleotides Nucleic Acids. 2007;26(6-7):865-8. doi: 10.1080/15257770701504033. Nucleosides Nucleotides Nucleic Acids. 2007. PMID: 18066915

8

Secretory synthesis of human interleukin-2 by Streptomyces lividans.

Bender E, Koller KP, Engels JW. Bender E, et al. Among authors: engels jw. Gene. 1990 Feb 14;86(2):227-32. doi: 10.1016/0378-1119(90)90283-w. Gene. 1990. PMID: 2323575

9

Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides.

Demirhan I, Hasselmayer O, Hofmann D, Chandra A, Svinarchuk FP, Vlassov VV, Engels J, Chandra P. Demirhan I, et al. Virus Genes. 1995 Jan;9(2):113-9. doi: 10.1007/BF01702654. Virus Genes. 1995. PMID: 7732657

10

Backbone modified oligodeoxynucleotides: stereoselective synthesis of methylphosphonates and HIV inhibitory capacity of phosphorothioates.

Engels JW, Daum T, Frauendorf A, Lüking S, Mag M, Müller WE, Muth J, Rosmanitz P. Engels JW, et al. Nucleic Acids Symp Ser. 1991;(24):83-6. Nucleic Acids Symp Ser. 1991. PMID: 1841388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters